Maduro celebrates Argentinean-Mexican initiative to produce Covid-19 vaccine

The President of the Republic, Nicolás Maduro, celebrated this Sunday the initiative of Argentina and Mexico to produce the vaccine developed by the University of Oxford against Covid-19 for the whole Latin America.

“Be welcome the initiative of Alberto Fernández (president of Argentina) and Andrés Manuel López Obrador (Mexico) to produce the vaccine developed by Oxford”, said the Venezuelan head of state.

Said vaccine that will be produced by Mexico and Argentina would be ready in the first quarter of 2021.

The eventual AstraZeneca vaccine that Mexico and Argentina will produce against COVID-19 could be available in the first quarter of 2021, as assured the Mexican president, Andrés Manuel López Obrador, last Thursday (08/13/2020).

According to the Mexican government, the objective is to guarantee the access of Latin American countries to the vaccine, developed by the alliance of the University of Oxford with the Anglo-Swedish AstraZeneca laboratory. Brazil is not included because it has a separate agreement.

Mexican Chancellor Marcelo Ebrard will lead a virtual meeting of the Community of Latin American and Caribbean States (CELAC) this Monday to present this agreement on the vaccine and its distribution in the region, as reported the body, which Mexico currently chairs, on a Twitter message.

For its part, the Mexican pharmaceutical company Liomont announced that it will be in charge of the final manufacture of the potential vaccine. Specifically, it will receive the raw material manufactured by the Mabxience laboratory in Argentina for the final production of the vaccine at its plant in Mexico,as confirmed the company in statements to the media.